These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 6713415
1. Correlation between estrogen-receptor proteins and response to chemotherapy in patients with breast cancer. Kiang DT. Cancer Treat Rep; 1984 Apr; 68(4):577-9. PubMed ID: 6713415 [No Abstract] [Full Text] [Related]
2. Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer. Levine RM, Lippman ME. Cancer Treat Rep; 1984 Apr; 68(4):573-6. PubMed ID: 6370427 [No Abstract] [Full Text] [Related]
3. Adjuvant chemotherapy of early breast cancer. Med Lett Drugs Ther; 1990 May 18; 32(818):49-50. PubMed ID: 2333039 [No Abstract] [Full Text] [Related]
4. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM. Clin Cancer Res; 2007 Apr 15; 13(8):2329-34. PubMed ID: 17438091 [Abstract] [Full Text] [Related]
6. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials. Albain KS. J Natl Cancer Inst; 2004 Dec 15; 96(24):1801-4. PubMed ID: 15601631 [No Abstract] [Full Text] [Related]
7. HER2 and response to paclitaxel in node-positive breast cancer. Mehta R. N Engl J Med; 2008 Jan 10; 358(2):197-8; author reply 198. PubMed ID: 18193531 [No Abstract] [Full Text] [Related]
8. [In vitro sensitivity of breast cancer tissue to adriablastin in the presence and absence of estrogen receptors]. Olinia AIa, Vitola GIa, Nuke IIa, Zeĭkate GA, Emzin'sh DE. Vopr Onkol; 1984 Jan 10; 30(3):14-6. PubMed ID: 6710944 [Abstract] [Full Text] [Related]
10. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer. Benson JR. J Clin Oncol; 2005 Sep 20; 23(27):6807-9. PubMed ID: 16170197 [No Abstract] [Full Text] [Related]
11. [Steroid hormone receptors in breast cancer (a review of the literature)]. Korolev VI, Dziubko NIa, Tarutinov VI. Vrach Delo; 1988 Nov 20; (11):86-91. PubMed ID: 2853492 [No Abstract] [Full Text] [Related]
13. [Adjuvant therapy in breast cancer]. Semiglazov VF. Vopr Onkol; 2000 Nov 20; 46(1):18-27. PubMed ID: 10789218 [No Abstract] [Full Text] [Related]
14. [Role of biological indicators in the therapeutic decision in breast carcinoma]. Amadori D, Maltoni R. Chir Ital; 1995 Nov 20; 47(4):15-22. PubMed ID: 9005127 [Abstract] [Full Text] [Related]
15. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Foekens JA, Peters HA, Grebenchtchikov N, Look MP, Meijer-van Gelder ME, Geurts-Moespot A, van der Kwast TH, Sweep CG, Klijn JG. Cancer Res; 2001 Jul 15; 61(14):5407-14. PubMed ID: 11454684 [Abstract] [Full Text] [Related]
18. The stability of estrogen and progesterone receptors in patients receiving preoperative chemotherapy for locally advanced breast carcinoma. Jain V, Landry M, Levine EA. Am Surg; 1996 Feb 15; 62(2):162-5. PubMed ID: 8554195 [Abstract] [Full Text] [Related]